News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
427,138 Results
Type
Article (30561)
Company Profile (45)
Press Release (396532)
Section
Business (138493)
Career Advice (1538)
Deals (22344)
Drug Delivery (85)
Drug Development (49020)
Employer Resources (98)
FDA (10394)
Job Trends (10416)
News (223877)
Policy (20817)
Tag
Academia (1833)
Alliances (37529)
Alzheimer's disease (925)
Antibody-drug conjugate (ADC) (70)
Approvals (10388)
Artificial intelligence (131)
Bankruptcy (183)
Best Places to Work (8387)
Breast cancer (139)
Cancer (1011)
Cardiovascular disease (87)
Career advice (1311)
Cell therapy (209)
Clinical research (38958)
Collaboration (412)
COVID-19 (1755)
Cystic fibrosis (70)
Data (1040)
Diabetes (143)
Diagnostics (4088)
Earnings (58079)
Employer resources (89)
Events (60437)
Executive appointments (268)
FDA (10841)
Funding (314)
Gene therapy (148)
GLP-1 (488)
Government (2904)
Healthcare (12358)
Infectious disease (1822)
Inflammatory bowel disease (90)
Interviews (273)
IPO (9604)
Job creations (2385)
Job search strategy (1102)
Layoffs (298)
Legal (5509)
Lung cancer (152)
Lymphoma (77)
Manufacturing (174)
Medical device (8020)
Medtech (8024)
Mergers & acquisitions (12887)
Metabolic disorders (386)
Neuroscience (1171)
NextGen Class of 2024 (4405)
Non-profit (3940)
Northern California (1074)
Obesity (219)
Opinion (181)
Patents (90)
People (34760)
Phase I (11570)
Phase II (16673)
Phase III (13878)
Pipeline (466)
Policy (71)
Postmarket research (1861)
Preclinical (5020)
Radiopharmaceuticals (162)
Rare diseases (201)
Real estate (3438)
Regulatory (13380)
Research institute (1678)
Resumes & cover letters (235)
Southern California (883)
Startups (2287)
United States (9743)
Vaccines (449)
Weight loss (178)
Date
Today (2)
Last 7 days (405)
Last 30 days (1635)
Last 365 days (23766)
2024 (23658)
2023 (25986)
2022 (33958)
2021 (35304)
2020 (34467)
2019 (31304)
2018 (23659)
2017 (21573)
2016 (21037)
2015 (23683)
2014 (19405)
2013 (16702)
2012 (16854)
2011 (16391)
2010 (15032)
Location
Africa (637)
Arizona (74)
Asia (25442)
Australia (4079)
California (2327)
Canada (939)
China (215)
Colorado (123)
Connecticut (132)
Europe (58704)
Florida (386)
Georgia (101)
Illinois (254)
Indiana (166)
Maryland (365)
Massachusetts (1881)
Michigan (142)
Minnesota (154)
New Jersey (778)
New York (743)
North Carolina (527)
Northern California (1074)
Ohio (92)
Pennsylvania (577)
South America (866)
Southern California (883)
Texas (342)
Utah (77)
Washington State (248)
427,138 Results for "bill and melinda gates foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Dr. Patrice Matchaba Appointed as Chief Executive Officer of the Bill & Melinda Gates Medical Research Institute
The Bill & Melinda Gates Medical Research Institute announced the appointment of Patrice Matchaba, MD, as Chief Executive Officer, starting June 10, 2024.
May 28, 2024
·
3 min read
Press Releases
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates Foundation for Thermostable mRNA Delivery Formulation Development
October 30, 2024
·
3 min read
Press Releases
Immorna Receives Grant from Bill & Melinda Gates Foundation to Support Its mRNA RSV Vaccine Clinical Development
August 26, 2024
·
4 min read
Amidst Ongoing Global Crises, Gates Foundation Announces Largest Annual Budget Ever: $8.6 Billion in 2024 to Save and Improve Lives
The Bill & Melinda Gates Foundation announced its largest annual budget to date as it works toward the goal of a healthier, more prosperous world for all.
January 15, 2024
·
7 min read
Earnings
Bayer Earnings ‘Not Pretty,’ CEO Bill Anderson Admits As He Urges Calm
Bayer reported a decline of 37% in earnings per share on Tuesday, which sent its stock down 12%. CEO Bill Anderson urged investors to be patient as the company executes on a performance-boosting strategy outlined in March.
November 12, 2024
·
2 min read
·
Annalee Armstrong
Owlstone Medical Secures $6.5 Million to Support Development of Breath-based Diagnostics for Infectious Disease
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation (“the Gates Foundation” or “the foundation”).
April 25, 2024
·
3 min read
Bill & Melinda Gates Foundation Announces Additional Support to Promote Locally Led R&D; Calls for Proposals
The Bill & Melinda Gates Foundation announced a series of initiatives and a call for proposals to advance locally-led innovation that supports work by scientists and researchers in developing economies.
October 24, 2022
·
4 min read
BioForest
Gates Foundation Celebrates 20 Years of “Grand Challenges” With New Investments and a Call to Make R&D Breakthroughs Available More Quickly and Equitably
A slate of new initiatives to support locally led innovation was announced in Dakar by the Bill & Melinda Gates Foundation and its partners at the Grand Challenges Annual Meeting.
October 10, 2023
·
7 min read
Genetown
Nanite Awarded $1.8M to Develop AI-driven Gene Therapy for HIV
Nanite, Inc. announced a $1.8M grant from the Bill & Melinda Gates Foundation to design and optimize polymeric delivery vehicles to deliver DNA-encoded therapeutics.
May 8, 2024
·
2 min read
BioCapital
Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research
Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has signed a three-year agreement with the Bill & Melinda Gates Medical Research Institute to provide its adjuvant for use in preclinical vaccine research.
June 5, 2023
·
4 min read
1 of 42,714
Next
